In Vivo Liquid Biopsy of Melanoma (Cytophone)

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

February 11, 2025

Primary Completion Date

February 11, 2026

Study Completion Date

March 31, 2026

Conditions
MelanomaCirculating Tumor CellsMetastatic MelanomaDiagnosis
Interventions
DEVICE

Cytophone

"The Cytophone clinical prototype incorporates two pulse lasers, optical system for delivery of laser light to the skin, ultrasound transducer array and detection electronics for acquisition of acoustic waves from CTCs.~Parameters of lasers:~C-Wedge 1064 (Bright Solutions, Cura Carpignano (PV), Italy): Wavelength,1064 nm; pulse width, 0.6 ns; pulse rate: 1 kHz; pulse energy, 240 μJ.~C-Wedge 18901 (Bright Solutions, Cura Carpignano (PV), Italy):~Wavelength, 770 nm; pulse width 3 ns; pulse rate, 1 kHz; pulse energy, 240 μJ. Detection of acoustic waves from CTCs is performing by a focused ultrasound transducer array placed in an acoustic contact with the skin of the subject with ultrasound gel. The signals from the transducers are amplified with a 16 channel amplifier, then digitized by a 12-bit, 500 MSPS high speed board digitizer (ATS9350, AlazarTech, Canada). This information is then transferred to a data recording system using a secure computer."

Trial Locations (1)

53715

RECRUITING

SSM Health Dean Medical Group Specialty Services, Madison

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cytoastra

INDUSTRY